本页面由Tiger Trade Technology Pte. Ltd.提供服务

Definium Therapeutics

36.79
+2.617.64%
成交量:80.74万
成交额:2,905.75万
市值:49.43亿
市盈率:-10.56
高:37.10
开:34.85
低:34.57
收:34.18
52周最高:49.70
52周最低:10.46
股本:1.34亿
流通股本:1.30亿
量比:1.22
换手率:0.62%
股息:- -
股息率:- -
每股收益(TTM):-3.4823
每股收益(LYR):-2.0600
净资产收益率:-64.09%
总资产收益率:-20.64%
市净率:5.38
市盈率(LYR):-17.86

数据加载中...

2026/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/14

重要事件披露

Form 8-K - Current report
2026/09/08

重要事件披露

Form 8-K - Current report
2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/22

重要事件披露

Form 8-K - Current report